Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2009
10/08/2009US20090253624 Pharmacologically active antiviral peptides and methods of use
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253618 Neuronal differentiation-inducing peptide and use thereof
10/08/2009US20090253615 No-modified hemoglobins and uses therefor
10/08/2009US20090253207 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
10/08/2009US20090253206 Nuclear transport agent and method for producing said agent
10/08/2009US20090253205 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
10/08/2009US20090253201 Embryonic stem cells capable of differentiating into desired cell lines
10/08/2009US20090253177 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength
10/08/2009US20090253172 Growth factor homolog zvegf4
10/08/2009US20090253168 improving the membrane permeability of a substrate, hydantoin-transporter activity; obtained by introducing and expressing the novel gene called mhp
10/08/2009US20090253166 Conjugation of Peptides
10/08/2009US20090253152 NOVEL MUTANT IGFBP-3 MOLECULES THAT DO NOT BIND TO IGFs, BUT RETAIN THEIR ABILITY TO FUNCTIONALLY BIND IGFBP-3 RECEPTOR
10/08/2009US20090253146 Methods of expressing integrin beta6 subunits
10/08/2009US20090253136 Genetic risk assessment technology for epithelial cancer involving gene-environment interaction between ercc5 and tobacco use
10/08/2009US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
10/08/2009US20090252766 Attenuated gram negative bacteria
10/08/2009US20090252761 Papilloma virus vaccine
10/08/2009US20090252755 nucleic acid molecule comprising a hepatitis C virus (HCV) 5' untranslated region (UTR), produces a HCV that infects chimpanzees; for screening assays for the identification of antiviral agents for HCV
10/08/2009US20090252754 Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009US20090252747 Immunization; used to elicit a humoral or cellular immune response
10/08/2009US20090252738 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009US20090252736 Mammalian Genes; Related Reagents
10/08/2009US20090252735 Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same
10/08/2009US20090252731 Multivalent Carriers of Bi-Specific Antibodies
10/08/2009US20090252728 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
10/08/2009US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009US20090252715 Immortalization of mammalian cells
10/08/2009US20090252713 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
10/08/2009US20090252705 IL-6/IL-6R Fusion Protein
10/08/2009US20090252688 Magnetic resonance contrast medium containing an iron-binding protein
10/08/2009DE19932688B4 Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen Design of beta-sheet proteins of the gamma-II-crystallin antibody-like
10/08/2009DE102005031755B4 Salmonella spp. Salmonella spp. bindende Peptide, dafür kodierende Nukleinsäuren deren Verwenduen und Verfahren und Kits zur Anreicherung, Immobilisierungen und zum Nachweis von Salmonella spp. binding peptides, nucleic acids encoding the Verwenduen and methods and kits for enrichment, immobilization and detection of Salmonella spp.
10/08/2009CA2720380A1 Use of defensins against meningitis
10/08/2009CA2720306A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/08/2009CA2720277A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009CA2720173A1 Highly bridged peptides from actinomadura namibiensis
10/08/2009CA2720166A1 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
10/08/2009CA2720053A1 Composition, kit and method for assaying neuropathy
10/08/2009CA2720051A1 Composition, kit, and method for assaying ageing and disease accompanied with vascular disorder
10/07/2009EP2107374A1 Polypeptide for diagnosis of vaccination
10/07/2009EP2107128A2 Novel polynucleotides
10/07/2009EP2107118A1 Fertile transgenic maize plants and methods for their production
10/07/2009EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D)
10/07/2009EP2107069A2 Novel insulin derivatives
10/07/2009EP2107068A1 MZB1, a novel B cell factor, and uses thereof
10/07/2009EP2106802A1 Modified peptides as synthetic vaccines in amyloid-associated disease
10/07/2009EP2106801A1 IL-25 for use in the treatment of inflammatory diseases
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106447A1 Method for methanol independent induction from methanol inducible promoters in pichia
10/07/2009EP2106407A2 Novel peptides for use in the treatment of obesity
10/07/2009EP2106406A2 Novel peptides for use in the treatment of obesity
10/07/2009EP2106405A2 Peptides for use in the treatment of obesity
10/07/2009EP2106210A1 C-reactive protein (crp) knockout mouse
10/07/2009EP1773995B1 Site specific system for generating diversity protein sequences
10/07/2009EP1722229B1 Method of assessing risk of and predisposition to the development of a pathology related to the presence of anti-epcr antibodies
10/07/2009EP1680678B1 Recombined cell system for deorphanizing g protein-coupled receptors
10/07/2009EP1617216B1 Novel method of screening
10/07/2009EP1584627B1 Dimerized peptide
10/07/2009EP1477562B1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
10/07/2009EP1434791B1 Specific binding agents of human angiopoietin-2
10/07/2009EP1421112B1 Novel serine protease
10/07/2009EP1283872B1 Catalytically active peptides
10/07/2009EP1191099B1 Novel polypeptide and dna thereof
10/07/2009EP1187917B1 Cd44 splice variant associated with rheumatoid arthritis
10/07/2009EP1105460B1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
10/07/2009EP1053329B1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
10/07/2009EP0907735B2 Modulators of tissue regeneration
10/07/2009EP0907730B1 Haemopoietin receptor and genetic sequences encoding same
10/07/2009EP0840736B1 Improved synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
10/07/2009CN101553985A A/D converter, A/D converting method, A/D converting program and control apparatus
10/07/2009CN101553728A The use of Granulin-Epithelin Precursor (GEP) antibodies for detection and suppression of Hepatocellular carcinoma (HCC)
10/07/2009CN101553569A Abiotic stress tolerance conferred by J-domain-containing proteins
10/07/2009CN101553501A Il-21变种 Il-21 variant
10/07/2009CN101553499A Process for generation of protein and uses thereof
10/07/2009CN101553255A Smallpox monoclonal antibody
10/07/2009CN101550417A A cDNA sequence of Tamarix androssowii ferritin gene and encoded amino acid sequence
10/07/2009CN101550187A Method for preparing phenothiazine immunizing antigens and antibodies thereof
10/07/2009CN101550186A Sheep recombination prion protein and monoclonal antibody thereof and application
10/07/2009CN101550185A New tumor-related gene or protein and application thereof
10/07/2009CN101550184A Marking protein on tumor drug-resistant film surface and application thereof as drug-resistant tumor drug target protein
10/07/2009CN101550183A Antibacterial peptide and construction and application thereof
10/07/2009CN101550182A Swine hepatitis E virus epitope and application thereof
10/07/2009CN100547078C Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger
10/07/2009CN100547074C Reconstruction of HIV-1 Chinese epidemic strain gag gene and recombination DNA vaccine thereof
10/07/2009CN100547073C Permeases 2,5-DKG
10/07/2009CN100547072C Method for breeding low-heavy metal resistance plant
10/07/2009CN100547070C Attenuated circovirus
10/07/2009CN100547069C Production of viruses, viral isolates and vaccines
10/07/2009CN100547002C Gene artificial synthesis and SARS virus protective antigen-amino acid series
10/07/2009CN100547001C HBV precore protein capable of forming particles
10/07/2009CN100546647C P185-encoding DNA and therapeutical uses thereof
10/06/2009USRE40930 Porcine adenovirus type 3 genome
10/06/2009US7598440 Plants and seeds of corn variety CV940888
10/06/2009US7598436 Hybrid corn plant and seed PP59302
10/06/2009US7598366 TaBV transcriptional control elements, chimeric constructs and uses therefor
10/06/2009US7598365 Using rare-cleaving "double stranded break" inducing enzymes; improved I-SceI encoding nucleotide sequences
10/06/2009US7598362 Hepatitis C virus vaccine
1 ... 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 ... 2916